US92337R1014
US92337R1014
Vera Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 315.473.000 | 167.170.000 | 88.7% | |
| Operating Income | -315.473.000 | -167.170.000 | 88.7% |
| Pretax Income | -299.614.000 | -152.147.000 | 96.9% |
| Net Income Common Stockholders | -299.615.000 | -152.148.000 | 96.9% |
| -- | -- | -- | |
| -- | -- | -- |